NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Genesis Research and Development Corporation 

Ontogen Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 





 Company News
ImmunoGen, Inc. (IMGN) Licenses Anti-Cancer Technology to Amgen (AMGN) (JOBS); ImmunoGen to Get Up to $34 Million in Milestone Payments 11/20/2009 6:39:39 AM    More...
Amgen (AMGN) to Present at Lazard Capital Healthcare Conference 11/17/2009 10:39:31 AM    More...
Amgen (AMGN) to Present at 18th Annual Credit Suisse Healthcare Conference 11/12/2009 11:14:09 AM    More...
Study Confirms Clot Risks with Amgen (AMGN) (JOBS), Johnson & Johnson (JNJ) (JOBS) Anti-Anemia Drugs 11/11/2009 8:22:34 AM    More...
Amgen (AMGN) (JOBS) Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer; Fails to Meet Secondary Endpoint of Overall Survival 11/5/2009 6:28:30 AM    More...
Amgen (AMGN)'s Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to $1.49 10/22/2009 8:59:24 AM    More...
US FDA Delays Approval of Amgen (AMGN) (JOBS) Osteoporosis Drug 10/19/2009 7:10:27 AM    More...
Amgen (AMGN) Announces Webcast of 2009 Third Quarter Financial Results 10/16/2009 9:09:23 AM    More...
Amgen (AMGN) May Takeover Savient Pharmaceuticals, Inc. (SVNT) to Gain Access to Experimental Gout Drug 10/16/2009 7:05:18 AM    More...
Amgen (AMGN)'s (JOBS) Bone Drug May Face Delays In FDA Decision 10/16/2009 7:03:18 AM    More...
12345678910...